Stocks and Investing Stocks and Investing
Mon, January 27, 2025
[ Last Monday ] - MSN
MP Materials' SWOT analysis: rare earth stock's vertical integration strategy
[ Last Monday ] - MSN
Got $3,000? 2 Monster Growth Stocks to Buy Right Now Without Hesitation
[ Last Monday ] - MSN
TKO Group Holdings CEO Emanuel Ariel acquires $47.9 million in stock
[ Last Monday ] - MSN
Brokers just upgraded these 3 ASX stocks to buys
[ Last Monday ] - MSN
Karyopharm Therapeutics' SWOT analysis: biotech stock faces pivotal year
[ Last Monday ] - MSN
Diworsification: When too much diversification hurts your investments
[ Last Monday ] - MoneyWeek
DeepSeek: Chinese chatbot sends shockwaves through US stock market
[ Last Monday ] - MSN
STAG Industrial's SWOT analysis: diverse portfolio shields stock amid market shifts
[ Last Monday ] - MSN
3 Blue-Chip Retail Stocks You Can Trust for Long-Term Gains
[ Last Monday ] - Kiplinger
Stock Market Today: Markets Tumble on DeepSeek Shock
[ Last Monday ] - WOPRAI
Short squeeze is starting in shares of KVUE at $2 .. 9, after crossing above the $21.473 Trigger Price
[ Last Monday ] - Forbes
Super Micro Computer Stock: Where Is It Heading In 2025?
[ Last Monday ] - MSN
The one Australian stock to buy and hold forever in an ASX share portfolio
[ Last Monday ] - WOPRAI
Short squeeze is starting in shares of ESCA at $1 .. 5, after crossing above the $15.896 Trigger Price
[ Last Monday ] - Investopedia
The Surprising Role Alternative Investments Play in Portfolio Diversification
[ Last Monday ] - MSN
Billionaires Selling AI Stocks to Buy This ETF that Has 42% Upside According to Wall Street Guru
[ Last Monday ] - WOPRAI
Brian Brophy Maintained (ECG) at Buy with Increased Target to $85 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Joshua Chan Maintained (KLC) at Buy with Decreased Target to $28 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Stephen Gengaro Maintained (SEI) at Buy with Increased Target to $42 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Justin Jenkins Initiated (CCEC) at Outperform and Held Target at $26 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Daniel Ives Maintained (OKLO) at Outperform with Increased Target to $45 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Nathan Jones Maintained (VLTO) at Buy with Decreased Target to $116 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Nathan Jones Maintained (ESAB) at Hold with Increased Target to $131 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Yatin Suneja Reiterated (VIGL) at Buy on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Nathan Jones Maintained (ZWS) at Hold with Increased Target to $39 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Jeremy Tonet Maintained (DTM) at Neutral with Increased Target to $115 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Grant Joslin Initiated (INDI) at Neutral and Held Target at $4.5 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Andres Coello Maintained (ASTS) at Sector with Decreased Target to $40 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Mark Zhang Initiated (DOCN) at Buy and Held Target at $45 on, Jan 24th, 2025
[ Last Monday ] - WOPRAI
Li Watsek Reiterated (ALXO) at Overweight on, Jan 24th, 2025

Li Watsek Reiterated (ALXO) at Overweight on, Jan 24th, 2025


Published on 2025-01-27 14:07:58 - WOPRAI
  Print publication without navigation


Li Watsek of Cantor Fitzgerald, Reiterated "ALX Oncology Holdings Inc." (ALXO) at Overweight on, Jan 24th, 2025.

Li has made no other calls on ALXO in the last 4 months.



There is 1 other peer that has a rating on ALXO. Out of the 1 peers that are also analyzing ALXO, all agrees with Li's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Michael Yee of "Jefferies" Downgraded at Hold and Decreased Target to $2 on, Thursday, December 19th, 2024
Contributing Sources